As Rhode Island commenced adult-use sales last week, growers will look to compete against those vying for cultivation notoriety. However, one operator’s experience serves as a reminder for those operating in the nascent market.

The state told Rhode Island-based cultivator Mammoth Inc. that it has to cough up $10,000 after the grower took home the top prize in March for a THC flower strain at the New England Cannabis Convention (NECANN).

Photo by Tetra Images/Getty Images

The issue? The competition took place at the Hynes Convention Center in Boston — across the state border. The state’s Office of Cannabis Regulation eventually caught wind of the development after the company posted the win on its Instagram page.

The fine was to be paid in four installments over a nine-month period, with the second payment due at the end of this month.

The enforcement serves as a cautionary tale for businesses looking to subvert the still-current federal prohibition of transporting cannabis product across state lines.

RELATED: International Cannabis Reform Ramps Up In Europe, South America

In a September document, regulators stated that Mammoth transported 28 one-gram samples across state lines to be entered into the competition nearly a month prior.

The company’s attorney, Lisa Holley, told NBC 10 WJAR that the company had a booth at the convention but did not sign up for the competition itself, contending that there is no evidence that points to Mammoth as the party that transported the product to Massachusetts.

RELATED: Bill Would Make Cannabis Companies Eligible For SBA Loans

“They accepted it. That’s what they did wrong,” Holley told the outlet, adding that Mammoth believes someone entered its cannabis in the competition because they liked the product.

This article originally appeared on Green Market Report and has been reposted with permission.

Green Market Report

Source link

You May Also Like

Los Angeles Finance Co. To Fund Expansion Projects In Cannabis Sector With $15M Credit Line

XS Financial Inc.  XSHLF  has entered into a $15 million line of credit…

America’s Leading Cannabis and CBD brand Launches in Europe.

EQS-News: Ambari Brands Inc. / Key word(s): MiscellaneousAmericas Leading Cannabis and CBD…

Receptor Life Sciences Opens Second Investigational New Drug (IND) Application with FDA for RLS103 (Inhaled Dry Powder CBD) for the Treatment of Rapid Epileptic Seizure Termination (REST)

SEATTLE–(BUSINESS WIRE)–Receptor Life Sciences (RLS), a pharmaceutical company developing innovative therapies to…

Equity Incentives and Cannabis Businesses

A common way to get and retain employees is to issue them…